Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Semaglutide for Sale > 910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - large image1
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image1
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image2
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image3
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image4
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image5
910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration buy - image6

910463-68-2 Semaglutide lyophilized reagent powder for laboratory model exploration

TDS 421 Inquiries

Unit Price: Get Latest Price
CAS No.:

910463-68-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shenzhen

Brand:

XiWu

Packaging:

20mg*10Vials

Price valid (until):

2026-09-20

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


       Product Detail  


    Whatsapp:+85244697127

    If you are interested, please feel free to contact me at any time.

    Product Introduction

    Semaglutide, CAS 910463‑68‑2, is a fatty‑acid‑modified long‑acting synthetic GLP‑1 receptor agonist peptide. It is provided as high‑quality white to off‑white lyophilized powder dedicated to pre‑clinical laboratory research. Strict quality control is implemented throughout production process. Each production batch is fully characterized and verified testing to ensure the purity reaches ≥99%. Complete supporting files including COA, batch test reports and specification sheets are accessible upon customer inquiry. This modified synthetic peptide is extensively utilized in life‑science research, focusing on GLP‑1‑associated receptor signaling pathways, peptide structural modification study and diverse pre‑clinical biological model exploration for experimental observation.

    Mechanism of Action

    Semaglutide functions as a GLP‑1 receptor agonist. In experimental cell and animal models, it binds and activates GLP‑1 receptor to trigger downstream intracellular signaling cascades for laboratory observation. Its lipid‑modified structural feature contributes to improved molecular stability in research‑related experimental systems.

    Chemical Information

    • CAS No.: 910463‑68‑2
    • Compound Name: Semaglutide
    • Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
    • Molecular Weight: 4113.58
    • Appearance: White to off‑white lyophilized powder
    • Purity: ≥99%
    • Solubility: Soluble in bacteriostatic sterile water

    Storage Condition

    Sealed storage. Short‑term store at 2‑8℃; long‑term preserve at ‑20℃. Avoid repeated freeze‑thaw cycles, strong light and moisture.

    Research Applications

    GLP‑1 receptor related pre‑clinical mechanism research, metabolic signal pathway study, life‑science laboratory projects.

    Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 1 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 2 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 3 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 4 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 5 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 6 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 7


    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 6 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 7



    Items Specifications
    Product Name
    Semaglutide Peptide Lyophilized Powder
    Purity ≥99%
    Packing Way Foam + Carton


    Packaging & Logistics

    Standard packing: 2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg sealed vial.

    Outer package: Foam box + carton. Transportation: Normal cold chain transportation is optional. Goods will be well sealed to prevent moisture.

    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 8 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 9


    Company Profile


    We are a high-tech enterprise oriented towards research and development, specializing in the fields of pharmaceutical raw materials, intermediates, peptide components, cosmetic raw materials, and nutritional supplement raw materials. We offer standardized large-scale production services and conduct global wholesale business. Our multiple peptide raw materials possess core physiological effects such as weight loss, muscle building, blood sugar reduction, and anti-aging, are widely applicable to the research and production demands in the pharmaceutical, beauty, and health care sectors.

    We adopt strict batch production standards and have sufficient production capacity and stable supply capabilities. All products have been professionally tested by third-party institutions and come with complete test reports and qualification certificates, ensuring stable batch quality and complete traceability. For large-scale orders, we offer competitive wholesale prices. We uphold the core values of integrity, pragmatism, innovation and development, and continuously enhance our technical strength and product quality.


    We offer comprehensive high-quality fine raw materials for the pharmaceutical, cosmetic and nutritional product industries. At the same time, we not only support standard batch purchases but also can meet the needs of pilot projects and large-scale industrial production.


    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 10 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 11

    ECHEMI Editorial Reference

    Semaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.

    Certificates

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 307, No. 3, Building 7, Area 4, Pingchou, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Inquiry History
    421 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Semaglutide

    1 G Oct 27, 2026
    Belgium

    Semaglutide

    1 MT Oct 19, 2026
    Chile

    Semaglutide

    10 MG Oct 16, 2026
    Slovakia

    semaglutide

    10 MG Oct 15, 2026
    Germany

    Semaglutide

    1 G Oct 14, 2026
    South Africa

    Semaglutide

    10 MT Oct 11, 2026
    United States

    Semaglutide

    1000 MT Oct 6, 2026
    United States

    Semaglutide

    10 MT Sep 30, 2026
    United States

    Semaglutide

    1000 KG Sep 30, 2026
    United States

    Semaglutide

    30 MG Sep 28, 2026
    United States

    Semaglutide

    10 MT Sep 25, 2026
    Philippines

    Semaglutide

    10 MG Sep 20, 2026
    India

    Semaglutide

    10 MG Sep 18, 2026
    United Kingdom

    Semaglutide - Reta - Tirz

    100 MG Sep 17, 2026
    United Kingdom

    Semaglutide

    10 G Sep 17, 2026
    United Kingdom

    Retatruide

    1 MT Sep 15, 2026
    United Kingdom

    IGF-1 LR3

    10 MT Aug 28, 2026
    Paraguay

    Semaglutide Freeze-dried Vial

    1 KG Aug 27, 2026
    United States

    Semaglutide

    2 MT Aug 25, 2026
    United States

    Semaglutide

    1 MT Aug 24, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.